Aether Industries Limited will participate in the Ambit-Daiwa India Access investor conference in Singapore on August 17-18, 2026. The engagement provides investors with physical one-on-one and group meeting opportunities with company management. The company has explicitly confirmed that no Unpublished Price Sensitive Information (UPSI) is intended to be discussed during these sessions, ensuring compliance with market disclosure norms.

The announcement was made through a filing dated August 10, 2026, submitted to both the BSE Limited and the National Stock Exchange of India Limited. The intimation was issued under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which mandates timely disclosure of such corporate events to ensure equal access to information for all stakeholders.

Conference Schedule Details

The company outlined the specific details of its participation in the investor conference as follows:

The meetings are scheduled to take place in a physical format, allowing for direct interaction between management and institutional or retail investors. This format is typical for major international investor conferences where detailed strategic discussions often occur.

Compliance and Disclosures

Chitrarth Rajan Parghi, Company Secretary and Compliance Officer of Aether Industries Limited, signed the submission. He holds Membership No. F12563. The filing serves as an official record for the stock exchanges, ensuring that the schedule is available for public scrutiny.

The company noted that the schedule is subject to change by either the organizer or the company itself. Investors are advised to monitor official communications for any updates regarding timing or format changes. As per standard regulatory practice, the absence of UPSI discussions means that any strategic insights shared will be limited to publicly available information or general outlooks already disclosed in previous filings.

What This Means for Investors

Participation in international conferences like Ambit-Daiwa India Access signals the company’s active engagement with global capital markets. Such events allow management to articulate their vision and address queries from analysts and fund managers directly. For shareholders, this represents an opportunity to gain clarity on the company’s operational trajectory and strategic priorities without the risk of selective disclosure of sensitive data.

Aether Industries Limited delivered robust financial performance in the first quarter of fiscal year 2027, driven by strong demand in its contract manufacturing segments and successful capacity utilization at new sites. Consolidated revenue from operations rose by 27% year-on-year to ₹3,266 million, up from ₹2,566 million in the corresponding quarter of the previous fiscal year. Net profit after tax (PAT) increased by 33% to ₹627 million, compared to ₹470 million in Q1 FY26. EBITDA grew by 31% to ₹1,028 million, expanding margins from 30% to 31%. This growth underscores the company’s strategic shift towards higher-margin contract models and its ability to scale complex chemistries.

The financial filing was submitted to BSE Limited and National Stock Exchange of India Limited in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The earnings conference call was held on July 31, 2026, with participation from Dr. Aman Desai, Promoter and Whole Time Director; Mr. Rohan Desai, Promoter and Whole Time Director; and Mr. Faiz Nagariya, Chief Financial Officer. Management highlighted that the final insurance claim for fixed assets lost in the November 29, 2023 fire accident was received during the quarter, completing the recovery process.

Financial Performance Highlights

The company’s profitability metrics improved across the board, reflecting operational efficiency and favorable product mix shifts. The PAT margin widened to 19% from 18% in the prior year period. Capital expenditure for the quarter stood at ₹943 million, with full-year guidance for FY27 set between ₹3,000 million and ₹3,500 million. These investments are primarily directed towards Site 5 (Magnum) and the new R&D facility.

Strategic Expansion and New Partnerships

Aether Industries announced a landmark exclusive multi-year research collaboration with Dow Chemical to develop new manufacturing technologies for silicones. The program will be conducted at Aether’s R&D and pilot plant facilities in Surat, Gujarat. Dr. Aman Desai noted that silicones are a strategically important class of high-performance materials, with India currently importing the bulk of its foundational molecules. This partnership aims to address India’s multi-billion-dollar silicones market through indigenous technology development, leveraging Aether’s core competencies in process chemistry and scale-up capabilities.

Additionally, the company began commercial sales of new Large Scale Manufacturing (LSM) products from its Magnum site (Site 5) in Panoli during the quarter. These products, priced in the $30 to $40 per kilo range, are designed for pharmaceutical, agrochemical, and material science applications. Rohan Desai stated that these molecules are being manufactured in India for the first time, representing a clear import substitution opportunity. The company expects these products to contribute to revenue starting in Q2 FY27.

Operational Updates and Capacity Utilization

Site 3++, commissioned in February 2026, is ramping up as expected and contributing meaningfully to commercial output. Site 5, dedicated to Baker Hughes and oil and gas sector requirements, continues to scale on the back of long-term strategy contracts. Capacity utilization across existing plants was reported as follows: Site 2 at 74%, Site 3 at 69%, and Site 4 at 59%.

Management emphasized that the Contract Exclusive Manufacturing (CEM) and Contract Research and Manufacturing Services (CRAMS) models are becoming the backbone of the business, with CEM running at EBITDA margins north of 28% to 30%. In Q1 FY27, the company onboarded 10 new marquee clients and cleared more than nine customer certification audits. Working capital intensity remains a focus area, with inventory levels elevated due to strategic raw material positioning for Site 3++ and Site 5. However, management anticipates a progressive decline in working capital days as revenues from these new sites materialize.